• Bookmark this Page
  • Print this Page

News Room

Feinstein Institute Hosts First Merinoff World Congress

October 18, 2013

Kevin-J-Tracey-MD1.jpg

Kevin J. Tracey, president of the Feinstein Institute

MANHASSET, NY – The Feinstein Institute for Medical Research last week hosted a three-day conference, the Merinoff World Congress 2013: HMGB1, where more than 150 people attended to discuss the role of HMGB1 in biology and disease.

High-mobility group protein B1 (HMGB1), which was discovered by Feinstein Institute researchers, is a protein that can be a drug target for many inflammatory diseases, including lupus, rheumatoid arthritis and inflammatory bowel disease.

“The people who have come together for this meeting are excited because major scientific advances are being presented here for the first time,” said Kevin J. Tracey, MD, president of the Feinstein Institute. “We’re learning about how HMGB1 interacts with the nervous system and how it can be involved in chronic pain syndromes, cognitive problems, and even cancer. Discussing the latest advances in HMGB1 research will provide us with knowledge to ideally make medicines and treatments that will help future patients.” 

The Merinoff World Congress 2013: HMGB1 was held October 9-11. Lectures, meetings and poster sessions were held at the Feinstein Institute, located in Manhasset, and the Garden City Hotel. Attendees had the unique opportunity to learn about HMGB1 and network with the world's leading experts in the field. Topics addressed included the biology of HMGB1 structure and function, sterile inflammation and injury, release and signal transduction mechanisms, HMGB1 clinical measures and pathophysiology, and HMGB1 as a therapeutic target.

To learn more about the Merinoff World Congress 2013: HMGB1, click here.

About The Feinstein Institute for Medical Research

Headquartered in Manhasset, NY, The Feinstein Institute for Medical Research is home to international scientific leaders in many areas including Parkinson's disease, Alzheimer’s disease, psychiatric disorders, rheumatoid arthritis, lupus, sepsis, human genetics, pulmonary hypertension, leukemia, neuroimmunology, and medicinal chemistry. The Feinstein Institute, part of the North Shore-LIJ Health System, ranks in the top 6th percentile of all National Institutes of Health grants awarded to research centers. For more information, visit www.FeinsteinInstitute.org.

  • Media Contacts:

    Emily Ng, Research Communications Manager
    516) 562-2670
    eng3@nshs.edu
Back to Top